Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intr...
FDA Drug Recall #D-1537-2020 — Class I — July 22, 2020
Recall Summary
| Recall Number | D-1537-2020 |
| Classification | Class I — Serious risk |
| Date Initiated | July 22, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Kabi USA, LLC |
| Location | Lake Zurich, IL |
| Product Type | Drugs |
| Quantity | 25,100 bottles |
Product Description
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05
Reason for Recall
Cross Contamination with other products: trace amounts of lidocaine
Distribution Pattern
U.S.A. Nationwide
Lot / Code Information
Lot #: 6121853, Exp 05/2021; 6122207, Exp 06/2021
Other Recalls from Fresenius Kabi USA, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0432-2026 | Class II | 0.9% Sodium Chloride Injection, USP 900 mg per ... | Mar 11, 2026 |
| D-0427-2026 | Class II | 0.9% Sodium Chloride Injection, USP, (2,250 mg ... | Mar 11, 2026 |
| D-0434-2026 | Class II | 0.9% Sodium Chloride Injection, USP 900 mg per ... | Mar 11, 2026 |
| D-0428-2026 | Class II | 0.9% Sodium Chloride Injection, USP, (4,500 mg ... | Mar 11, 2026 |
| D-0424-2026 | Class II | 0.45% Sodium Chloride Injection, USP, 1.125 gra... | Mar 11, 2026 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.